Skip to main content
Your session has expired. Reloading...
Autoimmune

AMA Test

AMA is the key serological marker for primary biliary cholangitis. Including it in an autoimmune screen enables early detection and timely treatment initiation.

Doctor's Assessment Included

AMA (Anti-Mitochondrial Antibodies): what this test measures

This test detects and quantifies anti-mitochondrial antibodies in your blood. A positive result, particularly the M2 subtype, is highly specific for primary biliary cholangitis.

AMA (Anti-Mitochondrial Antibodies): why this value matters

AMA positivity with elevated alkaline phosphatase is sufficient for PBC diagnosis in most cases, often without the need for liver biopsy. Early detection enables treatment to slow disease progression.

AMA (Anti-Mitochondrial Antibodies): when is testing worthwhile?

Testing could be indicated when PBC is suspected: unexplained cholestatic liver enzyme elevation, chronic fatigue with pruritus, or as part of autoimmune liver disease evaluation.

AMA (Anti-Mitochondrial Antibodies): symptoms of a high or low value

Low Levels

A negative AMA result makes PBC unlikely but does not completely exclude it. A small percentage of PBC patients are AMA-negative.

High Levels

A positive AMA result strongly suggests PBC. Symptoms may include fatigue, pruritus (itching), dry eyes and mouth, and elevated liver enzymes. Some AMA-positive individuals remain asymptomatic for years.

AMA (Anti-Mitochondrial Antibodies): lifestyle and this value

If AMA-positive, consult a hepatologist for further evaluation. Avoid alcohol to protect liver function. Ursodeoxycholic acid (UDCA) is the standard treatment for PBC and can significantly slow disease progression when started early.

AMA (Anti-Mitochondrial Antibodies): frequently asked questions

Does a positive AMA always mean I have PBC?
AMA is highly specific for PBC but can rarely be found in other autoimmune conditions. Clinical correlation with liver enzymes and symptoms is important.
Can PBC be treated?
Yes. UDCA is effective in slowing disease progression in most patients. Early treatment significantly improves outcomes.
Is PBC hereditary?
PBC has a genetic component. First-degree relatives of PBC patients have a higher risk, though it is not directly inherited.

Medical reviewer

Medical standards

Dr. Naimi oversees the medical standards behind our content and assessments.

Medical policy
CIBG Ministerie van Volksgezondheid,
Welzijn en Sport Official BIG registration BIG 49928676701 Opens in a new tab

AMA (Anti-Mitochondrial Antibodies)

€39,-